1. Home
  2. CERT vs AXGN Comparison

CERT vs AXGN Comparison

Compare CERT & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CERT

Certara Inc.

N/A

Current Price

$6.65

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Axogen Inc.

AXGN

Axogen Inc.

N/A

Current Price

$32.19

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CERT
AXGN
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
CERT
AXGN
Price
$6.65
$32.19
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
$12.22
$36.11
AVG Volume (30 Days)
3.0M
737.2K
Earning Date
05-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
N/A
EPS
N/A
N/A
Revenue
$418,838,000.00
$225,208,000.00
Revenue This Year
$5.05
$19.81
Revenue Next Year
$5.73
$16.31
P/E Ratio
N/A
N/A
Revenue Growth
8.75
20.21
52 Week Low
$6.04
$9.22
52 Week High
$15.38
$36.00

Technical Indicators

Market Signals
Indicator
CERT
AXGN
Relative Strength Index (RSI) 34.35 51.61
Support Level $6.04 $29.13
Resistance Level $11.53 $34.26
Average True Range (ATR) 0.39 1.59
MACD 0.09 -0.15
Stochastic Oscillator 40.20 54.85

Price Performance

Historical Comparison
CERT
AXGN

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: